This is the first of a series of posts planned over the next few weeks. At the end of April, I finally attended my first in-person industry meeting in two years. I had the honor of presenting at the DTC National meeting during the Multicultural Health track, held in...
Originally published by Mobile Health News, Monday, September 28, 2020 Written by Laura Lovett This morning Abbott announced that its continuous glucose monitor the FreeStyle Libre 3 earned a CE mark, making it cleared for use for individuals with diabetes living in...
Diversity and Inclusion in Life Sciences After having been in the life sciences industry for more than 25 years I have seen impotent efforts at increasing diversity in clinical trials as well as hiring and promoting diverse employees. I was fortunate to make some...
Johnson & Johnson Launches Heartline™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke Johnson & Johnson, in collaboration with Apple, is offering eligible U.S. adults 65 years...
NORD Webinar: Life After Gene Therapy There was so -much interest in my posting about new drugs for sickle cell disease (SCD) I thought it would be helpful to amplify the future of managing SCD. Today NORD continues its gene therapy education series with a webinar...
This past week the FDA issued patient engagement guidance for medical devices . This guidance is in keeping with PFDD but, nonetheless, is still a draft – both encouraging AND frustrating. My assessment is that until PFDD and any related guidance is FINAL the...
